An alternative source of elevated tau phosphorylation in plasma following renal dysfunction

Abstract

Background: Build‐ups of β‐amyloid (Aβ) in the brain represent the earliest pathological signatures of Alzheimer's disease (AD). Recent studies have spotlighted phosphorylated tau protein ( p ‐tau) as a biomarker for the Aβ burden.